Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus. [Phase 2]
A Phase 2 trial evaluating the safety and tolerability of an intravenous dose of MEDI-546 in Japanese patients with systemic lupus erythemat…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE) [Phase 2]
Phase 2 clinical trial update for ILT-101 in active moderate-to-severe systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Synergetic B-cell Immodulation in SLE [Phase 2]
Phase 2 trial update for a B-cell modulation approach in systemic lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous [Phase 4]
Phase 4 clinical trial evaluating prophylactic trimethoprim/sulfamethoxazole to prevent severe infections in patients with systemic lupus er…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus [NA]
This completed clinical trial investigates whether increased GADD34 gene expression has prognostic value for patients with systemic lupus er…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus [Phase 2]
Phase II study evaluating safety and efficacy of ALX-0061 in systemic lupus erythematosus has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus [NA]
A clinical trial examines glucocorticoid withdrawal in early systemic lupus erythematosus. The trial status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus [Phase 2]
Phase 2 safety and efficacy study of a biologic for systemic lupus erythematosus has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) [Phase 2]
Phase 2 trial of baricitinib in systemic lupus erythematosus completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus. [Phase 2]
Phase 2 clinical trial evaluating safety and tolerability of MEDI-545 (injection) in patients with systemic lupus erythematosus has complete…
-
CLINICAL_TRIALS trial_result · 2018-11-09Clinical Trial Update: Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus [Phase 1]
Phase I study of belimumab in Chinese subjects with systemic lupus erythematosus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients [Phase 1]
Phase 1 trial updating safety and effectiveness of Gardasil in patients with systemic lupus erythematosus completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus [Phase 3]
Open-label extension study of Epratuzumab in systemic lupus erythematosus completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) [Phase 1, Phase 2]
Clinical trial update for nonmyeloablative conditioning and transplantation in refractory systemic lupus erythematosus (SLE) has terminated;…
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy [Phase 2]
Phase 2 pediatric trial results for belimumab added to background standard therapy in systemic lupus erythematosus have been completed and r…
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus [Phase 3]
A Phase 3 clinical trial comparing epratuzumab to placebo in moderate to severe systemic lupus erythematosus has completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) [Phase 3]
Phase 3 trial comparing epratuzumab to placebo in adults with moderate to severe systemic lupus erythematosus has completed; results posted …
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: A Study of LY2127399 in Participants With Systemic Lupus Erythematosus [Phase 3]
A Phase 3 trial evaluating LY2127399 (tabalumab) for systemic lupus erythematosus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-18Clinical Trial Update: Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE) [Phase 1]
This Phase 1 trial evaluated vitamin D therapy in patients with Systemic Lupus Erythematosus. The study sponsored by the Medical University …
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Intervention to Improve Quality of Life in African American Lupus Patients [NA]
Clinical trial update describing an intervention intended to improve quality of life for African American patients with systemic lupus eryth…
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus [Phase 3]
The Phase 3 trial of tabalumab (LY2127399) for systemic lupus erythematosus, using two injection methods, was terminated. Results were poste…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: A Study of LY2127399 in Participants With Systemic Lupus Erythematosus [Phase 3]
A Phase 3 clinical trial of LY2127399 in systemic lupus erythematosus has completed enrollment and posted results. The sponsor is Eli Lilly …
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus [Phase 2]
Phase 2a trial evaluating the efficacy and safety of ustekinumab in systemic lupus erythematosus has completed and results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus [Phase 2]
Phase 2 dose-ranging trial of Adcetris (brentuximab vedotin) in adults with systemic lupus erythematosus was terminated; results were posted…
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology
This clinical trial update describes a feasibility study of an immersive virtual reality-based biofeedback intervention for outpatients in r…